TY - JOUR
T1 - Beating non-communicable diseases in primary health care
T2 - The contribution of pharmacists and guidance from FIP to support WHO goals
AU - Sousa Pinto, Gonçalo
AU - Bader, Lina
AU - Billberg, Kristina
AU - Criddle, Deirdre
AU - Duggan, Catherine
AU - El Bizri, Luna
AU - Gharat, Manjiri
AU - Hogue, Michael D.
AU - Jacinto, Isabel
AU - Oyeneyin, Yetunde
AU - Zhou, Ying
AU - Laven, Anna
N1 - Publisher Copyright:
© 2019 Elsevier Inc.
PY - 2020/7
Y1 - 2020/7
N2 - According to the World Health Organization (WHO), more than 36 million people die annually from non-communicable diseases (NCDs), representing over 60% of deaths worldwide, 15 million of which occur before the age of 70 years. Prevention and control of NCDs and their risk factors require interventions that are therapeutically cost-effective, affordable by the patient and/or health systems and feasible, based upon local resources. This commentary paper sets a basis of global evidence to advocate, nationally and internationally, for an expanded role for pharmacists in NCD management by compiling best practices and examples. It encourages pharmacists around the world to act upon NCDs, from prevention and screening activities, to patient referral when appropriate, and to pharmacist-led, patient-centred NCD management to improve outcomes and quality of life. Priority NCDs fall into four areas: cardiovascular diseases, diabetes, asthma/chronic obstructive pulmonary disease and cancer. Building on the key roles they already play as primary healthcare professionals in the community, pharmacists can provide focused interventions, specialised counselling and care coordination, improving patient engagement to achieve better outcomes in the global fight against NCDs.
AB - According to the World Health Organization (WHO), more than 36 million people die annually from non-communicable diseases (NCDs), representing over 60% of deaths worldwide, 15 million of which occur before the age of 70 years. Prevention and control of NCDs and their risk factors require interventions that are therapeutically cost-effective, affordable by the patient and/or health systems and feasible, based upon local resources. This commentary paper sets a basis of global evidence to advocate, nationally and internationally, for an expanded role for pharmacists in NCD management by compiling best practices and examples. It encourages pharmacists around the world to act upon NCDs, from prevention and screening activities, to patient referral when appropriate, and to pharmacist-led, patient-centred NCD management to improve outcomes and quality of life. Priority NCDs fall into four areas: cardiovascular diseases, diabetes, asthma/chronic obstructive pulmonary disease and cancer. Building on the key roles they already play as primary healthcare professionals in the community, pharmacists can provide focused interventions, specialised counselling and care coordination, improving patient engagement to achieve better outcomes in the global fight against NCDs.
KW - Asthma
KW - COPD
KW - Cancer
KW - Cardiovascular
KW - Community
KW - Diabetes
KW - Disease management
KW - NCDs
KW - Non-communicable diseases
KW - Pharmaceutical care
KW - Pharmacists
KW - Pharmacy
KW - Prevention
KW - Primary health care
KW - Referral
KW - Screening
KW - Treatment optimisation
UR - http://www.scopus.com/inward/record.url?scp=85074403255&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85074403255&partnerID=8YFLogxK
U2 - 10.1016/j.sapharm.2019.10.008
DO - 10.1016/j.sapharm.2019.10.008
M3 - Comment/debate
C2 - 31668903
SN - 1551-7411
VL - 16
SP - 974
EP - 977
JO - Research in Social and Administrative Pharmacy
JF - Research in Social and Administrative Pharmacy
IS - 7
ER -